SPY308.08+2.53 0.83%
DIA257.85+2.58 1.01%
IXIC9,608.38+56.33 0.59%

HC Wainwright & Co. Reiterates Buy on Eyegate Pharmaceuticals, Announces $12 Price Target

HC Wainwright & Co. reiterates Eyegate Pharmaceuticals (NASDAQ:EYEG) with a Buy and announces $12 price target.

Benzinga · 05/19/2020 11:10

HC Wainwright & Co. reiterates Eyegate Pharmaceuticals (NASDAQ:EYEG) with a Buy and announces $12 price target.